Bill Text: NY A08560 | 2015-2016 | General Assembly | Introduced

New York Assembly Bill 8560 (Prior Session Legislation)

Introduced

Bill Title: Requires that insurance companies provide coverage for surveillance tests for ovarian cancer of insured individuals who are deemed to be at risk for ovarian cancer.

Spectrum: Partisan Bill (Democrat 13-0)

Status: (Introduced - Dead) 2016-01-06 - referred to insurance [A08560 Detail]

Download: New_York-2015-A08560-Introduced.html

                           S T A T E   O F   N E W   Y O R K
       ________________________________________________________________________
                                         8560
                              2015-2016 Regular Sessions
                                 I N  A S S E M B L Y
                                   October 30, 2015
                                      ___________
       Introduced   by   M.   of   A.  ORTIZ,  COOK,  COLTON,  CLARK,  GUNTHER,
         PEOPLES-STOKES, CAHILL, ENGLEBRIGHT, MILLER -- Multi-Sponsored  by  --
         M. of A. BRENNAN, FARRELL, GOTTFRIED, LUPARDO, RIVERA -- read once and
         referred to the Committee on Insurance
       AN ACT to amend the insurance law, in relation to providing coverage for
         surveillance tests for ovarian cancer
         THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
       BLY, DO ENACT AS FOLLOWS:
    1    Section 1. Subsection (i) of section 3216  of  the  insurance  law  is
    2  amended by adding a new paragraph 32 to read as follows:
    3    (32)  EVERY  POLICY  THAT  PROVIDES  MEDICAL, MAJOR-MEDICAL OR SIMILAR
    4  COMPREHENSIVE-TYPE COVERAGE  SHALL  PROVIDE  COVERAGE  FOR  SURVEILLANCE
    5  TESTS  FOR  OVARIAN  CANCER  FOR  AN  INSURED WHO IS AT RISK FOR OVARIAN
    6  CANCER. (A) FOR PURPOSES OF THIS SUBSECTION, AN INSURED IS DEEMED TO  BE
    7  AT RISK IF:
    8    (I) SHE HAS A FAMILY HISTORY OF:
    9    1. ONE OR MORE FIRST-DEGREE RELATIVE WITH OVARIAN CANCER;
   10    2. THREE OR MORE FEMALE RELATIVES WITH BREAST CANCER; OR
   11    3. NONPOLYPOSIS COLORECTAL CANCER; OR
   12    (II) SHE TESTS POSITIVE FOR BRCA1 OR BRCA2 MUTATIONS.
   13    (B)  FOR  PURPOSES  OF THIS SUBSECTION, SURVEILLANCE TESTS FOR OVARIAN
   14  CANCER SHALL MEAN ANNUAL SCREENING FOR OVARIAN CANCER USING:
   15    (I) CA-125 SERUM TUMOR MARKER TESTING;
   16    (II) TRANSVAGINAL ULTRASOUND; AND
   17    (III) PELVIC EXAMINATION.
   18    S 2. Subsection (k) of section 3221 of the insurance law is amended by
   19  adding a new paragraph 20 to read as follows:
   20    (20) EVERY GROUP OR BLANKET POLICY DELIVERED OR ISSUED FOR DELIVERY IN
   21  THIS STATE WHICH PROVIDES HOSPITAL, SURGICAL OR MEDICAL  COVERAGE  SHALL
   22  INCLUDE  COVERAGE  FOR  SURVEILLANCE  TESTS  FOR  OVARIAN  CANCER FOR AN
        EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                             [ ] is old law to be omitted.
                                                                  LBD04600-02-5
       A. 8560                             2
    1  INSURED WHO IS AT RISK FOR OVARIAN CANCER.  (A)  FOR  PURPOSES  OF  THIS
    2  SUBSECTION, AN INSURED IS DEEMED TO BE AT RISK IF:
    3    (I) SHE HAS A FAMILY HISTORY OF:
    4    1. ONE OR MORE FIRST-DEGREE RELATIVE WITH OVARIAN CANCER;
    5    2. THREE OR MORE FEMALE RELATIVES WITH BREAST CANCER; OR
    6    3. NONPOLYPOSIS COLORECTAL CANCER; OR
    7    (II) SHE TESTS POSITIVE FOR BRCA1 OR BRCA2 MUTATIONS.
    8    (B)  FOR  PURPOSES  OF THIS SUBSECTION, SURVEILLANCE TESTS FOR OVARIAN
    9  CANCER SHALL MEAN ANNUAL SCREENING FOR OVARIAN CANCER USING:
   10    (I) CA-125 SERUM TUMOR MARKER TESTING;
   11    (II) TRANSVAGINAL ULTRASOUND; AND
   12    (III) PELVIC EXAMINATION.
   13    S 3. Section 4303 of the insurance law is  amended  by  adding  a  new
   14  subsection (pp) to read as follows:
   15    (PP)  A HEALTH SERVICE CORPORATION OR MEDICAL EXPENSE INDEMNITY CORPO-
   16  RATION   WHICH    PROVIDES    MEDICAL,    MAJOR-MEDICAL    OR    SIMILAR
   17  COMPREHENSIVE-TYPE COVERAGE MUST PROVIDE COVERAGE FOR SURVEILLANCE TESTS
   18  FOR OVARIAN CANCER FOR AN INSURED WHO IS AT RISK FOR OVARIAN CANCER. (1)
   19  FOR PURPOSES OF THIS SUBSECTION, AN INSURED IS DEEMED TO BE AT RISK IF:
   20    (A) SHE HAS A FAMILY HISTORY OF:
   21    (I) ONE OR MORE FIRST-DEGREE RELATIVE WITH OVARIAN CANCER;
   22    (II) THREE OR MORE FEMALE RELATIVES WITH BREAST CANCER; OR
   23    (III) NONPOLYPOSIS COLORECTAL CANCER; OR
   24    (B) SHE TESTS POSITIVE FOR BRCA1 OR BRCA2 MUTATIONS.
   25    (2)  FOR  PURPOSES  OF THIS SUBSECTION, SURVEILLANCE TESTS FOR OVARIAN
   26  CANCER SHALL MEAN ANNUAL SCREENING FOR OVARIAN CANCER USING:
   27    (A) CA-125 SERUM TUMOR MARKER TESTING;
   28    (B) TRANSVAGINAL ULTRASOUND; AND
   29    (C) PELVIC EXAMINATION.
   30    S 4. This act shall take effect immediately and  shall  apply  to  any
   31  policy issued, renewed, or modified after such effective date.